Gene Biotherapeutics, Inc. Earnings Per Share (Basic)
Gene Biotherapeutics, Inc. reported Earnings Per Share (Basic) of $0.03 per share for the 3-month period ending 2020-06-30, per its 10-Q filed 2021-09-17.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2021-09-17
- Gene Biotherapeutics, Inc. earnings per share, basic for the quarter ending 2020-06-30 was $0.03.
- Gene Biotherapeutics, Inc. earnings per share, basic for the quarter ending 2019-12-31 was $0.10.
- Gene Biotherapeutics, Inc. earnings per share, basic for the quarter ending 2019-09-30 was -$0.01, a 133.33% decline year-over-year.
- Gene Biotherapeutics, Inc. earnings per share, basic for the quarter ending 2019-06-30 was -$0.02.
- Gene Biotherapeutics, Inc. earnings per share, basic for fiscal 2019 was $0.05.
- Gene Biotherapeutics, Inc. earnings per share, basic for fiscal 2018 was -$0.03.
- Gene Biotherapeutics, Inc. earnings per share, basic for fiscal 2017 was -$0.13.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|
| 2020-06-30 | $0.03 10-Q · filed 2021-09-17 | $0.02 10-Q · filed 2021-09-17 | |
| 2019-12-31 | $0.10 10-K · filed 2021-04-23 | $0.05 10-K · filed 2021-04-23 | |
| 2019-09-30 | -$0.01 10-K · filed 2021-04-23 | ||
| 2019-06-30 | -$0.02 10-Q · filed 2021-09-17 | -$0.03 10-Q · filed 2021-09-17 | |
| 2019-03-31 | -$0.02 10-K · filed 2021-04-23 | ||
| 2018-12-31 | -$0.02 10-K · filed 2021-04-23 | -$0.03 10-K · filed 2021-04-23 | |
| 2018-09-30 | $0.03 10-K · filed 2021-04-23 | ||
| 2018-06-30 | -$0.02 10-K · filed 2021-04-23 | ||
| 2018-03-31 | -$0.02 10-K · filed 2021-04-23 | ||
| 2017-12-31 | -$0.04 10-K · filed 2021-04-23 | -$0.13 10-K · filed 2021-04-23 | |
| 2017-09-30 | -$0.03 10-K · filed 2021-04-23 | ||
| 2017-06-30 | -$0.02 10-K · filed 2021-04-23 | ||
| 2017-03-31 | -$0.05 10-K · filed 2021-04-23 |